top of page

BLUEBERRIES MEDICAL CORP ANNUAL GENERAL MEETING 2023

BBM FS Q1'24

BBM MD&A Q1'24

BBM S211 REPORT FOR 2023

GENERAL INFORMATION

Blueberries Medical Corp. is a Latin American company with all the licenses granted by the Ministries of Justice and Health of Colombia, necessary to produce naturally grown premium Cannabis with low and high contents of THC and commercialize, manufacture and export derived products, with its primary operations ideally located in the Bogotá Savannah of central Colombia.

Blueberries Medical Corp is listed in the following markets: (CSE: BBM) (OTC: BBRRF) (FRA: 1OA)

INVESTOR PRESENTATION

2023

Q4 2023

Audited Consolidated Financial Statements For The Year Ended December 31, 2023

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three And Twelve Months Ended December 31, 2023

Q3 2023

Condensed Interim Consolidated Financial Statements For The Three And Nine Months Ended September 30, 2023

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three And Nine Months Ended September 30, 2023

Q2 2023

Condensed Interim Consolidated Financial Statements For The Six Months Ended June 30, 2023

Management's Discussion And Analysis Of Financial Condition And Results Of Operations For The Six Months Ended June 31, 2023

Q1 2023

Condensed Interim Consolidated Financial Statements For The Three Months Ended March 31, 2023

Management's Discussion And Analysis Of Financial Condition And Results Of Operations For The Three Months Ended March 31, 2023

INVESTOR RELATIONS

STOCK INFORMATION
bottom of page